KalVista Pharmaceuticals (KALV) Other Working Capital Changes (2016 - 2025)
KalVista Pharmaceuticals' Other Working Capital Changes history spans 10 years, with the latest figure at $1.3 million for Q2 2025.
- On a quarterly basis, Other Working Capital Changes fell 11.29% to $1.3 million in Q2 2025 year-over-year; TTM through Apr 2025 was $1.4 million, a 160.97% increase, with the full-year FY2025 number at $1.4 million, up 152.42% from a year prior.
- Other Working Capital Changes hit $1.3 million in Q2 2025 for KalVista Pharmaceuticals, up from -$2.1 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for KALV hit a ceiling of $1.4 million in Q2 2024 and a floor of -$2.1 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged $71142.9 across 3 years, with a median of $783000.0 in 2024.
- Biggest five-year swings in Other Working Capital Changes: dropped 21.93% in 2024 and later fell 11.29% in 2025.
- Tracing KALV's Other Working Capital Changes over 3 years: stood at -$1.8 million in 2023, then decreased by 19.27% to -$2.1 million in 2024, then soared by 160.88% to $1.3 million in 2025.
- Business Quant data shows Other Working Capital Changes for KALV at $1.3 million in Q2 2025, -$2.1 million in Q4 2024, and $783000.0 in Q3 2024.